Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11492646 Nuclease-mediated genome editing of primary cells

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
October 15, 2021
0
Date of Patent
November 8, 2022
0
Patent Application Number
17502421
0
Patent Citations
‌
US Patent 10900034 Guide RNA with chemical modifications
0
‌
US Patent 11193141 Nuclease-mediated genome editing of primary cells and enrichment thereof
‌
US Patent 10006052 Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and uses thereof
‌
US Patent 10006053 Use of chimeric nucleases to stimulate gene targeting
0
‌
US Patent 10072066 Methods and compositions for treatment of a beta thalessemia
‌
US Patent 10196651 Methods and compositions for treatment of a genetic condition
0
‌
US Patent 10208319 Therapeutic uses of genome editing with CRISPR/Cas systems
‌
US Patent 10293000 Methods and compositions for the treatment of lysosomal storage diseases
‌
US Patent 10337001 Guide RNA with chemical modifications
‌
US Patent 10369232 Allele selective gene editing and uses thereof
0
•••
Patent Citations Received
‌
US Patent 11634732 Pharmaceutical compositions comprising gene-corrected primary cells
0
Patent Inventor Names
Waracharee Srifa
0
Daniel P. Dever
0
Matthew H. Porteus
0
Rasmus O. Bak
0
Ayal Hendel
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11492646
0
Patent Primary Examiner
‌
Marcia S Noble
0

Find more entities like US Patent 11492646 Nuclease-mediated genome editing of primary cells

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.